2 of 5 listed pharmas are managed by multiple CEOs
2 of 5 listed pharmaceutical companies were reportedly managed by more than 2 CEOs.
It seems the system spreads for the intent of responsibly running a company with separated roles between shareholders and professional managers.
Yakup Shinmoon(www.yakup.com) analyzed CEOs at 65 KOSPI and KOSDAQ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
